IlluminOss Medical Launches the IlluminOss® Bone Stabilization System for Use in the Treatment of Traumatic and Fragility Fractures in the U.S. EAST PROVIDENCE, R.I., Feb. 26, 2019 (GLOBE NEWSWIRE) -- IlluminOss Medical, Inc., a privately held, commercial-stage medical device company focused on minimally invasive orthopedic fracture repair,...

IlluminOss Medical Receives Clearance to Expand Clinical Indications in the U.S. EAST PROVIDENCE, R.I. , Sept. 13, 2018 (GLOBE NEWSWIRE) -- IlluminOss Medical, a privately held, commercial-stage medical device company focused on minimally invasive orthopedic fracture repair,...

IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss® Bone Stabilization System EAST PROVIDENCE, R.I., Jan. 09, 2018 (GLOBE NEWSWIRE) -- IlluminOss Medical, a privately held, commercial-stage medical device company focused on minimally invasive orthopedic fracture repair, today...

IlluminOss Medical Secures $28 Million Series C Financing for Minimally Invasive Bone Fracture Repair EAST PROVIDENCE, RI--(Marketwire - Sep 27, 2012) - IlluminOss Medical, Inc., the company pioneering photodynamic orthopedic implants, announced today that it has secured a $28 million Series C round...